K receptor opioid peptides

A technology of opioid substances and receptors, applied in the field of synthetic opioid peptides, can solve problems such as polyuria
CN1283201AInactive Publication Date: 2001-02-07CARA THERAPEUTICS

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
CARA THERAPEUTICS
Publication Date
2001-02-07
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

Peptides which exhibit high selectivity for the kappa opioid receptor (KOR) and long duration of peripheral action without significant entry into the brain are created which are sequences of four D-isomer amino acid residues having a C-terminus which is a mono- or di-substituted amide. Representative compounds, which have an affinity for the KOR at least 1,000 times their affinity for the mu opioid receptor and an ED50 of not greater than about 0.5 mg / kg, include H-D-Phe-D-Phe-D-Nle-D-Arg-NHEt, H-D-Phe-D-Phe-D-Nle-D-Arg-morpholinyl, H-D-Phe-D-Phe-D-Nle-D-Arg-NH-4-picolyl, H-D-Phe-D-Phe-D-Nle-D-Arg-NHPr, H-D-Phe-D-Phe-D-Nle-D-Arg-thiomorpholinyl, H-D-Phe-D-Phe-D-Nle-D-Arg-NEt2, H-D-Phe-D-Phe-D-Nle-D-Arg-NHMe, H-D-Phe-D-Phe-D-Leu-D-Orn-morpholinyl, H-D-4Fpa-D-Phe-D-Nle-D-Arg-NH-4-picolyl, H-D-Phe-D-Phe-D-Nle-D-Arg-NH-cyclopropyl, H-D-Ala-(2Thi)-D-3, 4Cpa-D-Leu-D-Arg-morpholinyl, H-D-Phe-D-Phe-D-Nle-D-Gmf-morpholinyl, H-D-Phe-D-Phe-D-Leu-D-Orn-NH(Aeb), H-D-Phe-D-Phe-D-Leu-D-Lys-morpholinyl, H-D-Phe-D-Phe-D-Nle-D-Arg-piperazinyl, and H-D-Phe-D-Phe-D-Nle-D-Arg-NH(Hoh).
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates generally to synthetic opioid peptides, and in particular to opioid peptides that are highly selective κ receptor activators, and more particularly to activators that (a) do not penetrate the brain, and (b ) has long-term antinociceptive activity in vivo. Background of the invention

[0002] The kappa opioid receptor (KOR) is present in the brain, spinal cord, central and peripheral nerve endings, (somatic and visceral) primary sensory afferent nerve cell bodies, and immune cells. Molecules that activate KOR are generally referred to as kappa activators.

[0003] Activation of KOR in the brain is known to produce analgesic effects. Based on this finding, attempts were made to develop brain-permeable non-peptide κ activators as new analgesics to avoid the side effects (constipation, respiratory depression) of morphine analogs acting on the mu opioid receptor (MOR). , dependence and addiction). Such compounds have bee...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More